Letters to the Editor: California can't take all the blame for Las Vegas' tourism decline
Before tourism in Vegas decreased, its expenses were already high, from fast food combo meals costing at least $30 to cocktails pricing at $25, not to mention the typical price of a hotel room being more than $160 per night. With Californians dealing with our own economic struggles, Vegas is just way too expensive to vacation to, which could also be a major reason for Vegas tourism declining.
Madison Fujimoto, Gardena
..
To the editor: Castleman's article on tourism being down in Las Vegas should be a wake-up call to and an opportunity for California. We know that the world is not enamored with President Trump.
But we still need tourism, so let's set ourselves apart from Trump's America. All tourists to California should get an across-the-board 10% reduction on hotel rooms, meals, ride-share services and tickets to museums and theme parks. Let's put the welcome mat out to the world.
Chuck Heinz, West Hills
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Apple leads surge in global tech shares after Trump tariff relief
(Reuters) -Global technology stocks advanced on Thursday in a relief rally after the latest tariff salvo from U.S. President Donald Trump largely exempted industry heavyweights from his threat to impose 100% levy on chips and semiconductors. Trump said the new tariff rate would apply to "all chips and semiconductors coming into the United States," but would not apply to companies that had made a commitment to manufacture in the U.S. or were in the process of doing so. Apple's stock rose 3.3% in premarket trading after Trump's announcement on Wednesday that the company will invest an additional $100 billion in the U.S., a move that could help it sidestep potential tariffs on iPhones. U.S.-listed chipmakers advanced broadly, with Advanced Micro Devices up 2.5%, Intel gaining 2.1% and Nvidia up 1.1%. "A major uncertainty has been removed and investors can finally move on," UBS analysts said in a note. Semiconductor manufacturing equipment supplier Applied Materials and chipmakers Texas Instruments, GlobalFoundries and Broadcom - Apple's partners in the investment effort - climbed between 0.8% and 10.1%. European chipmakers also joined the rally, with ASML, ASMI and BE Semiconductor Industries climbing about 3% each. Germany's Infineon said it could not speculate on possible semiconductor tariffs, as no details have been disclosed yet. Its shares were up 0.6%. Trump's latest on semiconductor tariffs seemingly rules out Taiwanese chip contract manufacturer TSMC, which makes chips for most U.S. companies, including Nvidia, as it has factories in the U.S. "The market remains keen to buy TSMC on dips. Investors also believe they need to remain positioned in AI - with or without tariffs," UBS analysts said. TSMC shares closed almost 5% higher to hit all-time highs, while Samsung Electronics and SK Hynix climbed 2.5% and 1.4%, respectively. South Korea's Samsung and SK Hynix will also not be subjected to 100% tariffs on chips, the country's top trade envoy said. Samsung has invested in two chip fabrication plants in Austin and Taylor, Texas, while SK Hynix has announced plans to build an advanced chip packaging plant and research and development facility for artificial intelligence products in Indiana. Since stepping into the White House in January, Donald Trump has made several tariff threats, specifically on semiconductors, aimed at reshaping the supply chain of the industry and spurring domestic production. "The (100% tariff) figure fits Trump's approach of 'open high, negotiate down' and the final figure could be similar to reciprocal tariffs to limit inflation in consumer goods, given that many have chips," said Phelix Lee, senior equity analyst at Morningstar. Not everyone has come out of the latest blitz on the right side, with the Philippines and Malaysia looking to find out more details about the tariff rate. Dan Lachica, the president of the trade body for the Philippine semiconductor industry, said 70% of its electronics exports are semiconductors and the new tariff rate would be "devastating". Philippine stocks were down 0.1% after falling as much as 0.9% during the day. Malaysia's trade minister said the country has reached out to U.S. counterparts for clarity on the tariffs. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Analysis-Struggling US healthcare stocks endure rough 2025 but draw some bargain hunters
By Lewis Krauskopf NEW YORK (Reuters) -Woes for U.S. healthcare stocks have worsened this year driven partly by Trump administration policies, although some investors are betting that the beaten-down shares are now becoming too much of a bargain to pass up. The S&P 500 healthcare sector -- which includes pharmaceutical companies, biotechs, health insurers and medical equipment makers -- has slumped 5% in 2025, lagging the over 7% gain for the overall index. Pressure to bring down U.S. prescription drug prices to overseas rates, tariffs targeted at pharmaceuticals and cuts to areas such as health research funding and Medicaid are among the Trump administration actions clouding the outlook for the shares this year, investors said. Regulatory obstacles are compounding issues, including expiring drug patents and setbacks for bellwethers including UnitedHealth Group. "You have got this constant overarching political and regulatory overhang that doesn't really seem to subside with any administration," said Jared Holz, healthcare sector strategist at Mizuho Securities. "When you have so much nebulousness around the sector, it turns people off rather than invites them to the party." In another sign of the group losing favor, healthcare exchange-traded-funds have seen 12 consecutive months of net outflows as of July for a total outflow of $11.5 billion in that time, more than for any other sector, according to State Street Investment Management. The performance picture is even dimmer over a longer period. While shares of massive technology companies pushed the benchmark S&P 500 up over 50% the past three years, the healthcare sector is little changed in that time. That gap has put the 60-stock sector at nearly its biggest discount to the broader market in 30 years, which some investors hope is an inflection point for the battered group. "The valuation is extremely cheap and the relative performance is at an extreme," said Walter Todd, chief investment officer at Greenwood Capital, whose healthcare holdings include diversified giant Johnson & Johnson and medical device maker Stryker. "So at this point, it seems like a pretty decent setup to get some outperformance." The price-to-earnings ratio for the healthcare sector, based on earnings estimates for the next year, has fallen to 16.2 times from nearly 20 a year ago, according to LSEG Datastream. Meanwhile, the S&P 500's rally to records has driven the index's P/E ratio to over 22 times -- giving the broader market a significant premium over the healthcare sector. 'BAD NEWS IS PRICED IN' Some high-profile healthcare names are at even cheaper valuations. For example, Merck is trading at a forward P/E of 8.7, against its long-term average of 14.5, while fellow drugmaker Bristol Myers Squibb trades at 7.4 against its average of 15.8, according to LSEG. Year-to-date, shares of both Merck and Bristol Myers are down roughly 20%. The group is drawing bets from some value investors such as Patrick Kaser, portfolio manager at Brandywine Global, whose portfolio is overweight the sector including owning shares of CVS Health and European drugmakers GSK and Sanofi. "Our perspective is a lot of this bad news is priced in and then some," Kaser said. "To bet against the sector from here, you're essentially continuing to bet on the valuation gap, which is already large, continuing to widen." The group's decline means the total market value of the S&P 500 healthcare sector is about $4.8 trillion, not much higher than the $4.3 trillion value of Nvidia, the semiconductor company that has symbolized the artificial intelligence boom. Indeed, some investors said a shift in capital away from Nvidia and other massive tech companies could spark healthcare shares. Such a move appeared to occur in the first quarter, investors said, when the healthcare sector rose 6% while declines in tech and megacap stocks dragged indexes lower. Fears of an economic downturn also could help healthcare shares, at least on a relative basis. The group is often viewed as a defensive area in rockier economic times. Economic fears flared following last Friday's weaker-than-expected employment report, while some strategists say the market could be due for a pullback after surging over 20% since its April lows. "During the first quarter, healthcare did great even as tech rolled over, as the fears of an economic slowdown got to more economically sensitive stocks," said Chris Grisanti, chief market strategist at MAI Capital Management, adding he expects healthcare "will perform better in a more difficult market." More clarity on regulatory issues, including tariffs, also could support healthcare, investors said. But some value investors are hesitant to dive into the group. Michael Mullaney, director of global markets research at Boston Partners, said he is wary some healthcare shares could be "value traps," preferring to overweight areas including industrials or financials. "There's been just so much of an overhang in the sector," Mullaney said. "There are better places to go with cleaner stories." Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
26 minutes ago
- San Francisco Chronicle
Independent candidate for Michigan governor is betting on partisan fatigue in the midterms
DETROIT (AP) — Detroit Mayor Mike Duggan spent his political career as a Democrat, leading Michigan's largest Democratic stronghold. But now, he's become a target of his former party, whose leaders are furious about his decision to run for Michigan governor next year as an independent. Detroit is a power base for Democrats in the battleground state, and some fear Duggan will draw support from their nominee and potentially help the Republican candidate. Democrats have launched attacks against Duggan, accusing him of being bankrolled by allies of President Donald Trump. But Duggan — who is soon leaving the office he has held since 2014 — says voters of all leanings are tired of partisan fighting. 'It doesn't actually matter where I go in the state,' Duggan said. 'People are angry that their problems are not getting solved because the two parties are so consumed with fighting with each other.' Duggan had been a major Democratic figure in Michigan with a close working relationship with former President Joe Biden. While there is precedent for independent governors in the U.S., none are currently in office and there has never been one in Michigan. Why run as an independent? He announced his bid a month after Democrats suffered heavy losses in the 2024 election. But, midterm elections tend to favor the party not in power. Democrats have now seized on cuts to Medicaid and SNAP benefits as winning issues in races across the country. Duggan doesn't see it that way. 'I mean, it would have been easier to win as a Democrat, but then I'd have just been part of the partisan problem,' Duggan said. As an example, Duggan pointed to Michigan's split Legislature, with Republicans in control of the state House and Democrats controlling the state Senate. Only six proposals have become law this year, and the state operating budget is still hung up. Duggan's campaign has focused on his independency from both parties and education in the state. Duggan derided Michigan House Democrats who voted against a measure to restrict cellphone usage in schools. 'I don't really intend to get involved in the national Republican versus Democratic talking points,' he said. Tariffs in Detroit, and abroad Several companies in Michigan's auto industry, centered in Detroit, have reported major losses and expressed worry about tariffs imposed by the Trump administration. Auto parts often move across the border between the U.S. and Canada multiple times during manufacturing. Duggan said tariffs on China and Mexico could push manufacturing to Michigan. However, tariffs on Canada are 'devastating,' he said. 'When you put a tariff on Canada, you put a tariff on Michigan,' he said. He also critiqued the ever-changing nature of Trump's tariff policies, saying they prevent companies from making educated, long-term investments. President Trump Duggan praised current Democratic Gov. Gretchen Whitmer for her work with the Trump administration, opposing the tariffs on Canada and working with him to get new fighter jets for an air force base. Some Democrats have criticized Whitmer for appearing with Trump multiple times this year. 'I think it's exactly the right kind of approach,' he said. Elon Musk Democrats in Michigan have frequently tied Duggan to Elon Musk; an attempt to undercut Duggan by association with the divisive public figure. Musk, a former Trump ally, said in July that he would create a third political party. When Duggan responded to Musk on X saying 'Now you've got my attention,' the Michigan Democratic Party said the mayor was 'cozying' up to the richest man in the world. When asked about exchange, Duggan said his bid is 'exactly the opposite' of a third party and said he wants no part of one. As an independent, he would not be responsible for any party majority, he said. 'I'm going to work with whoever wins to build bridges,' he said. Arab American voters Michigan is home to one of the largest populations of Arab American voters in the U.S., many of whom are disillusioned with both political parties over Israel's military offensive in Gaza which has resulted in a devastating humanitarian crisis. 'The governor doesn't make policy 6,000 miles away,' Duggan said. 'The governor has a great deal to say about the tone of hate speech and threats to individuals — whether it's the Jewish community, the Arab community — in the state of Michigan.' Who else is in the race? Whitmer is term-limited and cannot run for reelection. The crowded field vying to replace her includes three Democrats — Secretary of State Jocelyn Benson, Lt. Gov. Garlin Gilchrist II and Genesee County Sheriff Chris Swanson — and four Republicans — U.S. Rep. John James, state Senate Leader Aric Nesbitt, former state Attorney General Mike Cox and former Speaker of the state House Tom Leonard. Running as an independent allowed Duggan to avoid the Democratic primary, but he gave up access to the party's resources. He's well-known in Detroit and the surrounding areas but largely lacks statewide name recognition. Recent fundraising numbers showed Duggan was competitive with Benson, James and Nesbitt. Only Benson's campaign raised more than Duggan's, thanks to $1.1 million she transferred from her Secretary of State campaign account. National Democratic groups, though, are certain to prioritize the Michigan race and pour money in if needed. 'A lot of people in the state are fed up with a two party system,' Duggan said. 'And it's not going to change by electing another Republican or Democrat.'
